Akinobu Hamada
Impact in
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
Papers in
- Oncology 80
- Drug Transport and Resistance Mechanisms 17
- Lung Cancer Research Studies 16
- Cancer Treatment and Pharmacology 11
-
- Cancer therapeutics and mechanisms 14
- Co-authors
- Hideyuki Saito (34 shared papers)Hiroshi Watanabe (9 shared papers)Masahiro Nakano (7 shared papers)Noriko Iwamoto (12 shared papers)Takashi Shimada (13 shared papers)Kenji Tamura (25 shared papers)Takanobu Matsuzaki (6 shared papers)Kan Yonemori (24 shared papers)
- Journals
- Biological and Pharmaceutical Bulletin (14 papers)Journal of Clinical Oncology (10 papers)Annals of Oncology (8 papers)Cancer Chemotherapy and Pharmacology (7 papers)Cancer Science (7 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Akinobu Hamada
177 papers receiving 3.7k citations
Akinobu Hamada's Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 1.4k
- Hematology 314
- Genetics 272
- Pharmacology 180
- Pediatrics, Perinatology and Child Health 321
Countries citing papers authored by Akinobu Hamada
This map shows the geographic impact of Akinobu Hamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akinobu Hamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akinobu Hamada more than expected).
Fields of papers citing papers by Akinobu Hamada
This network shows the impact of papers produced by Akinobu Hamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akinobu Hamada. The network helps show where Akinobu Hamada may publish in the future.
Co-authors
The 25 scholars most cited alongside Akinobu Hamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor. | 2003 | 200 |
| 2 | 2008 | 154 | |
| 3 | 2003 | 130 | |
| 4 | 2014 | 125 | |
| 5 | 2006 | 117 | |
| 6 | 2015 | 89 | |
| 7 | Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2–Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial Hit paper breakdown → | 2023 | 89 |
| 8 | 2002 | 89 | |
| 9 | 2007 | 88 | |
| 10 | 2011 | 82 | |
| 11 | 2012 | 81 | |
| 12 | 2011 | 66 | |
| 13 | 2005 | 64 | |
| 14 | 2011 | 61 | |
| 15 | 2009 | 57 | |
| 16 | 2013 | 52 | |
| 17 | 2009 | 52 | |
| 18 | 2016 | 51 | |
| 19 | 2013 | 51 | |
| 20 | 2008 | 50 |
About Akinobu Hamada
Akinobu Hamada is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 181 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (22 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Drug Transport and Resistance Mechanisms (17 papers), Lung Cancer Research Studies (16 papers), Cancer therapeutics and mechanisms (14 papers), HIV/AIDS drug development and treatment (12 papers), Biosimilars and Bioanalytical Methods (11 papers) and Cancer Treatment and Pharmacology (11 papers). The work is most often cited by research in Oncology (1.4k citations), Hematology (314 citations), Genetics (272 citations), Pharmacology (180 citations) and Pediatrics, Perinatology and Child Health (321 citations). Akinobu Hamada has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hideyuki Saito, Hiroshi Watanabe, Masahiro Nakano, Noriko Iwamoto, Takashi Shimada, Kenji Tamura, Takanobu Matsuzaki, Kan Yonemori, Takeo Kawaguchi and Yasuhiro Fujiwara. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Journal of Clinical Oncology, Annals of Oncology, Cancer Chemotherapy and Pharmacology and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.